The Journal of Allergy and Clinical Immunology
Volume 124, Issue 6 , Pages 1186-1187, December 2009

New-onset mild asthma III: A sequel to 2 “Oscar winners”

  • Gene L. Colice, MD, FCCP

      Affiliations

    • Corresponding Author InformationReprint requests: Gene L. Colice, MD, FCCP, Washington Hospital Center, 110 Irving St, NW, Washington, DC 20010.

Pulmonary, Critical Care and Respiratory Services, Washington Hospital Center, George Washington University School of Medicine, Washington, DC

Received 29 October 2009; accepted 29 October 2009.

Key words: Asthma, inhaled corticosteroids, exacerbations, decline in lung function

No abstract is available. To read the body of this article, please view the Full Text online.

 

 Disclosure of potential conflict of interest: G. Colice is an advisor, speaker, and consultant for Almirall, Forest, Teva, GlaxoSmithKline, Behringer Ingelheim, Pfizer, Schering Plough, and Lilly.

PII: S0091-6749(09)01628-5

doi:10.1016/j.jaci.2009.10.051

Refers to article:

  • Thirteen-year follow-up of early intervention with an inhaled corticosteroid in patients with asthma

    Tari Haahtela, Klaus Tamminen, Tuomo Kava, L. Pekka Malmberg, Paula Rytilä, Kurt Nikander, Tore Persson, Olof Selroos
    The Journal of Allergy and Clinical Immunology December 2009 (Vol. 124, Issue 6, Pages 1180-1185)

The Journal of Allergy and Clinical Immunology
Volume 124, Issue 6 , Pages 1186-1187, December 2009